A double-blind, randomized, multicenter, phase II study of the safety and efficacy of two rituximab regimens in subjects with moderate to severe active rheumatoid arthritis receiving stable doses of methotrexate.
Phase of Trial: Phase II
Latest Information Update: 27 Nov 2014
At a glance
- Drugs Methotrexate; Rituximab
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Genentech
- 31 Aug 2018 Biomarkers information updated
- 06 Oct 2011 Actual initiation date changed from Apr 2006 to Aug 2005 as reported by ClinicalTrials.gov.
- 06 Oct 2011 Actual end date (Feb 2009) added as reported by ClinicalTrials.gov.